ILD/IPF Lineup at ATS 2023


The ATS 2023 International Conference offers a robust scientific program highlighting the cutting-edge advancements in pulmonary, critical care, and sleep medicine. This includes several sessions addressing new developments and considerations in interstitial lung disease and idiopathic pulmonary fibrosis, as listed below. A curated list of clinical and scientific sessions related to these topics also is available on the conference website. For more information on these and other sessions to be presented May 19–24 in Washington, DC, visit the online Program Itinerary.

  • A1. Clinical Year in Review 1
  • A88. Neuro-Immune Interactions in Lung Development and Disease
  • B12. ATS Clinical Practice Guidelines: Clinical Practice on the Cutting Edge
  • B82. The Genetics of Interstitial Lung Disease: Current State and Future Promise
  • C2. Endpoints for Therapeutic Trials in ILD
  • C83. Pro/Con: Hot Topics in Interstitial Lung Disease
  • C86. Beyond the Transcriptome: How The Multi-“Omic” Universe Provides Novel Insights into IPF/ILD Pathogenesis
  • D2. Cough in Pulmonary Fibrosis — Annoying Symptom or Driver/Marker of Disease Progression?

Don’t Miss ATS 2024 Highlights: On Demand

Don’t forget that ATS 2024 Highlights: On Demand are available to all conference registrants! On Demand will give you access to the Opening Ceremony, Plenary session, Keynote Series, Clinical Year in Review, Adult Clinical Core Curriculum, and so much more. The topics will cover ILD, asthma, health equity, and CF, to name just a few. On Demand content will be accessible to all ATS 2024 full conference and On Demand registrants until March 2025.